Newsletter Subject

OZY TV Spotlight: The Indomitable Dr. Albert Bourla

From

ozy.com

Email Address

info@daily.ozy.com

Sent On

Sat, Jul 2, 2022 08:55 PM

Email Preheader Text

Your daily deep dive into the topics and trends that are changing the world. www.ozy.com Your World.

Your daily deep dive into the topics and trends that are changing the world. www.ozy.com [OZY]() Your World. Bold & Bright [Daily Dose]( The newsletter to fuel — and thrill — your mind. Read for deep dives into the unmissable ideas and topics shaping our world. Jul 02, 2022 OZY TV SPOTLIGHT Talk about an unconventional rise to the top. [Dr. Albert Bourla]( went from treating animals as a clinical veterinarian to being the head of one of the biggest companies on the planet, Pfizer. Shortly after taking over as CEO, he oversaw the creation of a COVID-19 vaccine in a record amount of time. Bourla is proud this vaccine was developed and distributed with complete transparency, and he maintains the process was successful due to a determined global collaboration. On a personal level, he says he receives his greatest inspiration from the tenacity of his parents. Theirs is an inspiring story of survival and perspective. The beginning Proud Jewish roots Bourla was born and raised in Thessaloniki, Greece. He is the son of Sephardic Jewish parents who were among the 2,000 Thessaloniki Jews to survive the Holocaust (The vast majority — 54,000 of 56,000 — did not survive.) Bourla is deeply connected to his Jewish roots and credits his parents for instilling the belief that anything is possible. Theirs is an astonishing story of survival: Bourla’s mother managed to escape a Nazi firing squad, and his father narrowly avoided being sent to Aushwitz. Bourla often shares his parents' harrowing story in order to honor their struggle and remember all the lives violently extinguished in the Holocaust. Despite the abuse they witnessed and encountered, Bourla's parents taught him to celebrate life, emphasizing the importance of forgiveness rather than revenge. Pfizer calls Bourla, now age 60, lived in his hometown of Thessaloniki until 1993, when Pfizer recruited him to work as the technical director in its animal medicine division. As animal medicine receives considerably less financial backing, he had to think creatively to find alternative solutions. In his almost 30-year tenure at Pfizer, Bourla has revolutionized the customer care experience and also encouraged the massive company to shift to a more hands-on approach to medicine. He then played a major role in one of the most incredible private sector achievements in modern history, the COVID-19 vaccine. Never doubt Bourla insists that the speedy development of Pfizer's effective COVID-19 vaccine was due to the sheer determination and perseverance of the company’s approximately 80,000 global researchers, scientists, doctors and manufacturers. He listened carefully to the advice of his researchers and scientists on the front lines. Despite the naysayers and colossal pressures, the vaccine continues to save lives. “Growth never just happens, it’s created,” says Bourla. Creating the impossible Risky business Bourla is a self-described risk-taker. In 2001, following a series of promotions, he immigrated to the U.S., where he spent years in various managerial leadership roles for Pfizer. In 2014, he became the head of Pfizer’s global vaccines, oncology and consumer healthcare division. He then served as the group president of Pfizer Innovative Health, before becoming chief operating officer (COO) on way to his current CEO position. When the COVID-19 pandemic struck, he oversaw the reduction of the many bureaucratic steps needed for approval in the vaccine process without affecting the integrity of the procedure. About the vaccine's rapid development, he says it was incredible to witness, adding, “I realized that it would happen only after it happened.” The COVID connection Soon after first surfacing, COVID-19 was raging across the globe. Bourla knew there was a limited amount of time to create an effective vaccine before the second wave of the pandemic struck (it was the second wave of the 1918 influenza pandemic that had proved so massively lethal). Bourla credits his parents for teaching him to persevere in the face of adversity. This lesson guided him to his long-term success. A proud Greek American, he praises both countries for making him the person he is today. The inquisitive CEO The gift of a challenge Bourla studied veterinary medicine in his hometown of Thessaloniki and then went on to receive his Ph.D. in biotechnology of reproduction. Resilient and persistent while growing up, these traits endured into adulthood. Bourla is convinced that the challenges to developing the COVID-19 vaccine were necessary to obtain the desired result. And in order to create a more transparent development process, he welcomed open exchanges, discussions and questions. ‘Moonshot’ March 2022 saw the publication of Bourla's book, “Moonshot: Inside Pfizer’s Nine-Month Race to Make the Impossible Possible,” which focuses on the historically swift process in which Pfizer created, developed and rolled out the vital global vaccine. This book also gives insight into reforming the methods of future vaccine development. [TAKE OUR QUIZ]( WATCH ALBERT BOURLA on [The Carlos Watson Show](! A human touch Customer care Bourla’s leadership at Pfizer is one that puts patients and their health first and foremost. He created a transformational system that allows people to navigate Pfizer’s customer care platforms more efficiently, which vastly improves patient outcomes. He has also pushed his company to invest in ingenuity, investigation and effective development. The bigger picture The way Pfizer is operating under Bourla's leadership has set an example for how to contend with future pandemics and pharmaceutical advances in general. He does not look at science from a one-dimensional, sterile approach. Bourla constantly considers the human aspect of the company’s work; the one where people's lives are changed thanks to creativity and innovation in the field of medicine. [TAKE OUR QUIZ]( Community Corner What idea, innovation, person, or theme would you love to read about on OZY? Share your thoughts with us at OzyCommunity@Ozy.com. ABOUT OZY OZY is a diverse, global and forward-looking media and entertainment company focused on “the New and the Next.” OZY creates space for fresh perspectives, and offers new takes on everything from news and culture to technology, business, learning and entertainment. [www.ozy.com]( / #OZY Curiosity. Enthusiasm. Action. That’s OZY! [TV]( | [PODCASTS]( | [NEWS]( | [FESTIVALS]( A Modern Media Company OZY Media, 800 West El Camino Mountain View, California 94040 This email was sent to {EMAIL} [Manage Subscriptions]( | [Privacy Policy]( | [Read Online](

Marketing emails from ozy.com

View More
Sent On

28/02/2023

Sent On

28/02/2023

Sent On

27/02/2023

Sent On

27/02/2023

Sent On

26/02/2023

Sent On

26/02/2023

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.